Science meets extravagance
Tom Brady revealed that Junie was created by Colossal Biosciences, a Texas-based genetic engineering company in which he’s an investor. Scientists used a blood sample taken from Lua before her death to develop a genetically identical animal. While the company framed the project as a scientific breakthrough, public reaction was mixed. Some saw it as a touching tribute, others—like Sophie Cunningham—viewed it as an unnecessary indulgence.
Brady’s connection to Colossal goes beyond this personal case. The company has made headlines for its “de-extinction” ambitions, including efforts to revive species like the woolly mammoth. His investment aligns with his long-standing interest in health, longevity, and cutting-edge innovation. But this time, the partnership took a controversial turn.
A culture of excess?
Sophie Cunningham didn’t just criticize the act—she framed it as part of a broader culture of excess. Her reaction wasn’t isolated; animal welfare advocates have also raised concerns about the ethics of cloning pets for companionship. The question remains: how far is too far when it comes to replicating a living being out of emotional attachment?
While Tom Brady continues to push the boundaries of science, Sophie Cunningham stands firm on her own principles. Her stance seems rooted in values, consistency, and—above all—common sense.
